TL;DR
When people think about age-related macular degeneration, they naturally focus on what it means for their eyesight. But a growing body of research is asking a deeper question: what does AMD tell us about what’s happening in the brain?
The short answer is that the eye and the brain are more connected than most people realise – and scientists are increasingly interested in what that relationship means for how we understand, monitor, and even predict cognitive health in older adults.
The retina is an extension of the brain
This isn’t a metaphor. The retina is embryologically part of the central nervous system – it develops from the same tissue as the brain and remains directly connected to it via the optic nerve. When researchers and clinicians examine the retina, they are, in a very real sense, looking at an accessible window into the brain.
This is why AMD has attracted such attention from neuroscientists.
The retinal changes seen in AMD – including the accumulation of drusen deposits and the degeneration of retinal pigment epithelial cells – share striking similarities with processes observed in neurodegenerative conditions, particularly Alzheimer’s disease.
What AMD and Alzheimer’s have in common
The structural and biological overlaps between AMD and Alzheimer’s disease have been documented across multiple studies. Both conditions involve the build-up of amyloid beta deposits – a hallmark of Alzheimer’s – in the relevant tissue. In AMD, amyloid beta has been found within drusen, the waste deposits that accumulate beneath the macula. In Alzheimer’s, it collects in the brain as plaques.
Both conditions also share chronic inflammation and oxidative stress as central drivers of cell damage, and the same genetic risk factors – most notably variants in the complement system genes – have been identified in both. Cardiovascular risk factors such as high blood pressure, high cholesterol, and smoking are common to both as well.
Our expert’s opinion
This doesn’t mean that having AMD causes Alzheimer’s, or vice versa. But it does suggest these conditions may be driven by overlapping biological processes – and that’s significant for research.
What the studies say about cognitive risk
Several large-scale studies have now looked directly at whether people with AMD are at greater risk of developing dementia or cognitive decline.
A meta-analysis published in Ophthalmology – drawing on data from more than eight million participants – found that people with AMD had around a 22% higher risk of subsequently developing dementia, and a 21% higher risk of Alzheimer’s disease specifically. The association was more pronounced in dry AMD than wet AMD.
A separate study published in the British Journal of Ophthalmology followed approximately 12,000 adults for up to 15 years and found the risk of dementia was 26% higher among those with AMD. Importantly, people with more than one eye condition showed a compounding increase in risk.
It’s worth being clear about what these figures mean. A higher relative risk does not mean that dementia is inevitable – or even likely – for any individual with AMD. Many people live with macular degeneration for decades without any sign of cognitive decline. These studies identify associations and trends, not certainties.
Why vision loss itself may play a role
One important consideration is that some of the cognitive association may be explained – at least in part – by the effects of vision loss itself rather than shared biology alone. Poor vision reduces a person’s ability to engage with the world: reading less, socialising less, being less physically active. All of these are independently associated with accelerated cognitive decline.
This is one reason why treating AMD promptly and supporting people to maintain their quality of life – including helping them stay socially and mentally active – matters beyond just preserving sight. It’s also why low vision rehabilitation is such a valuable but underused resource, helping people adapt, stay independent, and remain engaged even when vision loss has already occurred.
The retina as a diagnostic tool
One of the more exciting frontiers emerging from this research is the idea of using the retina as a diagnostic window for brain health. Because retinal changes are visible and measurable non-invasively – through standard eye scans – researchers are investigating whether patterns in the retina might one day serve as early biomarkers for neurodegeneration, potentially flagging risk before symptoms appear in the brain.
This remains an active area of study rather than established clinical practice, but the direction of travel is clear: the eye is becoming an increasingly important tool in understanding what’s happening beyond it.
What this means for people with AMD
For anyone living with AMD, this research isn’t a reason to worry – it’s a reason to stay proactive about overall health. The risk factors that drive AMD progression are largely the same ones that affect brain health: smoking, cardiovascular health, diet, and inflammation. Addressing them benefits both.
Eating a diet rich in leafy greens, oily fish, and colourful vegetables supports both macular and cognitive health. The nutrients highlighted by the AREDS2 trial – lutein, zeaxanthin, vitamins C and E, and zinc – are specifically associated with reduced progression risk in AMD, and the broader antioxidant profile of such a diet has well-documented brain benefits too. There’s more on the controllable risk factors involved in AMD risk factors you can and can’t control.
Staying physically active, managing blood pressure, not smoking, and keeping socially connected are habits that protect both the macula and the mind. None of this is complicated – it’s the same evidence-based lifestyle advice that underpins healthy ageing more broadly.
The key takeaway
AMD is a condition of the eye – but it doesn’t exist in isolation from the rest of the body, and certainly not from the brain. The emerging science on the AMD-brain connection is genuinely fascinating, and it reinforces something important: looking after your eyes is part of looking after your health as a whole.
The information in this article is intended for general guidance only and does not replace advice from a qualified eye care professional. If you have concerns about your vision or overall health, please contact your optometrist or GP.
